Amid the COVID-19 crisis, the global market for Parenteral Nutrition estimated at US$5.4 Billion in the year 2020, is projected to reach a revised size of US$7.2 Billion by 2027, growing at a CAGR of 4.2% over the analysis period 2020-2027. Single Dose Amino Acid Solution, one of the segments analyzed in the report, is projected to record a 4.7% CAGR and reach US$2.6 Billion by the end of the analysis period. After an early analysis of the business implications of the pandemic and its induced economic crisis, growth in the Parenteral Lipid Emulsion segment is readjusted to a revised 4.7% CAGR for the next 7-year period.
The U.S. Market is Estimated at $1.5 Billion, While China is Forecast to Grow at 7.5% CAGR
The Parenteral Nutrition market in the U.S. is estimated at US$1.5 Billion in the year 2020. China, the world`s second largest economy, is forecast to reach a projected market size of US$1.6 Billion by the year 2027 trailing a CAGR of 7.5% over the analysis period 2020 to 2027. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 1.3% and 3.2% respectively over the 2020-2027 period. Within Europe, Germany is forecast to grow at approximately 2.2% CAGR.
Carbohydrates Segment to Record 3.8% CAGR
In the global Carbohydrates segment, USA, Canada, Japan, China and Europe will drive the 3.3% CAGR estimated for this segment. These regional markets accounting for a combined market size of US$724.8 Million in the year 2020 will reach a projected size of US$908.4 Million by the close of the analysis period. China will remain among the fastest growing in this cluster of regional markets. Led by countries such as Australia, India, and South Korea, the market in Asia-Pacific is forecast to reach US$1 Billion by the year 2027, while Latin America will expand at a 4.7% CAGR through the analysis period. We bring years of research experience to this 18th edition of our report. The 359-page report presents concise insights into how the pandemic has impacted production and the buy side for 2020 and 2021. A short-term phased recovery by key geography is also addressed.
Competitors identified in this market include, among others:
- Allergan plc
- Amanta Healthcare Ltd
- B. Braun Melsungen AG
- Baxter International Inc.
- Fresenius KABI AG
- Grifols International S.A.
- ICU Medical Inc.
- Otsuka Pharmaceutical Factory Inc.
- Sichuan Kelun Pharmaceutical Co. Ltd.
- Sino-Swed Pharmaceutical Corp. Ltd.
The global analysis and forecast periods covered within the report are 2020-2027 (Current & Future Analysis) and 2012-2019 (Historic Review). Research estimates are provided for 2020, while research projections cover the period 2021-2027.
I. INTRODUCTION, METHODOLOGY & REPORT SCOPE
II. EXECUTIVE SUMMARY
1. MARKET OVERVIEW
Parenteral Nutrition: Providing Essential Nutrition through Intravenous Feeding
Recent Market Activity
Malnutrition Related to Chronic Medical Conditions Fuels Demand for PN Products
The Road Ahead
Developed Economies Lead, Developing Regions to Propel Future Growth
Single Dose Amino Acid Solutions - Major Share of PN Solutions Market
Competitive Landscape
Global Competitor Market Shares
Parenteral Nutrition Competitor Market Share Scenario Worldwide (in %): 2020 & 2025
Parenteral Nutrition Competitor Market Share Scenario Worldwide (in %): 2020 & 2029
Impact of Covid-19 and a Looming Global Recession
2. FOCUS ON SELECT PLAYERS
Allergan plc (Ireland)
Amanta Healthcare Ltd (India)
B. Braun Melsungen AG (Germany)
Baxter International, Inc. (USA)
Fresenius KABI AG (Germany)
Grifols International S.A. (Spain)
ICU Medical, Inc. (USA)
Otsuka Pharmaceutical Factory, Inc. (Japan)
Sichuan Kelun Pharmaceutical Co., Ltd. (China)
Sino-Swed Pharmaceutical Corp. Ltd. (China)
3. MARKET TRENDS & DRIVERS
Clinical Nutrition Vital for Combating Malnutrition during Hospitalization
Increase in Healthcare Spending Bodes Well for Parenteral Nutrition Market
Rapidly Aging Demographics to Propel Demand for Parenteral Nutrition
Rising Incidence of Chronic Diseases to Propel Growth of Parenteral Nutrition Market
Cancer Patients - the Highest PN Users
Parenteral Nutrition: Critical for People with Gastrointestinal Disorders
Unrelenting Threat of HIV/AIDS Infection: An Opportunity for Parenteral Nutrition Market
Persistent Threat of HIV/AIDS - A Peek at Global HIV Statistics
Diabetes Mellitus: PN Therapy Indicated for Patients with Non-functional GI Tract
Global Diabetic Statistics - Opportunity Indicators
Rising Number of Premature Births Enhances Need for Parenteral Nutrition
Preterm Birth Statistics from WHO
Inadequate Physiological Development Raises Need for Tube Feeding in Infants
Nutritional Needs of Premature Infants: Mix of PN & EN Nutrition Emerges as Common Practice
Intravenous Therapy in Outpatient Settings to Boost Parenteral Nutrition Market
Growing Demand for Home Intravenous Nutritional Therapies
Rising Preference for Multi-Chamber Bags to Lower Cost of Parenteral Nutrition Therapy
Pre-mixed IV Nutrition: A Step towards Safer Medication Practices
Growing Demand for Low-Cost Parenteral Nutrition Solutions
Rising Popularity of Intravenous Vitamin C for Cancer Treatment
Increasing Demand for Peripheral Intravenous Nutrition
Iron Replacement Therapies - A Potential Market Segment
Popularity of TPN as Beauty Treatment Raises Ethical and Safety Concerns
Pharmaceutical Industry Participants Migrate from Concentrated Vials to Premixed Solutions
Vial Dilution and Potential Risks
Premixed Bags Present Efficient Delivery System
Switching from Vials to Premixed Bags
Challenges Confronting Production of Parenteral Products
Continuous Supply of Raw Material: Crucial for Production
Rising Preference for Enteral Nutrition: A Threat to Parenteral Nutrition Market
Infection Control: A Prime Concern in Parenteral Nutrition
Limiting Medication Errors - A Key Concern
4. GLOBAL MARKET PERSPECTIVE
III. MARKET ANALYSIS
GEOGRAPHIC MARKET ANALYSIS
UNITED STATES
Market Facts & Figures
US Parenteral Nutrition Market Share (in %) by Company: 2020 & 2025
Market Analytics
CANADA
JAPAN
CHINA
EUROPE
Market Facts & Figures
European Parenteral Nutrition Market: Competitor Market Share Scenario (in %) for 2020 & 2025
Market Analytics
FRANCE
GERMANY
ITALY
UNITED KINGDOM
SPAIN
RUSSIA
REST OF EUROPE
ASIA-PACIFIC
AUSTRALIA
INDIA
SOUTH KOREA
REST OF ASIA-PACIFIC
LATIN AMERICA
ARGENTINA
BRAZIL
MEXICO
REST OF LATIN AMERICA
MIDDLE EAST
IRAN
ISRAEL
SAUDI ARABIA
UNITED ARAB EMIRATES
REST OF MIDDLE EAST
AFRICA
IV. COMPETITION
Total Companies Profiled: 20
